Page 124 - 2018_12-Haematologica-web

P. Bories et al.
tests and treatments: measurement, preva-
lence, and relationship to sociodemograph- ic factors. J Health Commun. 2009;14(6): 556-572.
37. Nebout A, Dubois D. When Allais meets Ulysses: Dynamic axioms and the com- mon ratio effect. J Risk Uncertain. 2014;48(1):19-49.
38. Trautmann ST, van de Kuilen G. Ambiguity Attitudes. In: : G. Keren and G. Wu, editors. The Wiley Blackwell Handbook of Judgment and Decision Making. John Wiley & Sons, Ltd. 2015. p.89-116.
39. Nebout A, Cavillon M, Ventelou B. Comparing GPs’ risk attitudes for their own health and for their patients’ : a trou- bling discrepancy? BMC Health Serv Res. 2018;18(1):283.
40. Eckel CC and Grossman PJ. Men, Women and Risk Aversion: Experimental Evidence.
In: Plott, C. and Smith, V., Editors. Handbook of Experimental Economics Results. Elsevier. 2008. p. 1061-1073.
41. Croson R, Gneezy U. Gender Differences in Preferences. J Econ Lit. 2009; 47(2):448- 474.
42. Gattellari M, Voigt KJ, Butow PN, Tattersall MHN. When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J Clin Oncol. 2002; 20(2):503-513.
43. Han PKJ, Klein WMP, Lehman T, Killam B, Massett H, Freedman AN. Communication of uncertainty regarding individualized cancer risk estimates: effects and influen- tial factors. Med Decis Mak Int J Soc Med Decis Mak. 2011;31(2):354-366.
44. Dinmohamed AG, Visser O, van Norden Y, et al. Treatment, trial participation and sur- vival in adult acute myeloid leukemia: a population-based study in the
Netherlands, 1989-2012. Leukemia. 2016;
30(1):24-31.
45. Medeiros BC, Fathi AT, DiNardo CD,
Pollyea DA, Chan SM, Swords R. Isocitrate dehydrogenase mutations in myeloid malig- nancies. Leukemia. 2017;31(2):272-281.
46. Welch JS, Petti AA, Miller CA, et al. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med. 2016;375(21): 2023-2036.
47. Gerstung M, Papaemmanuil E, Martincorena I, et al. Precision oncology for acute myeloid leukemia using a knowl- edge bank approach. Nat Genet. 2017; 49(3):332-340.
48. Sorror ML, Storer BE, Fathi AT, et al. Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality. JAMA Oncol. 2017;3(12):1675-1682.
2048
haematologica | 2018; 103(12)